Regulation S-X
 
Rule 4-08
General Notes to Financial Statements
If applicable to the person for which the financial statements are filed,
the following shall be set forth on the face of the appropriate statement
or in appropriately captioned notes. The information shall be provided
for each statement required to be filed, except that the information required
by items (b),
(c),
(d), (e),
and (f) shall be provided as of the
most recent audited balance sheet being filed and for item
(j)
as specified therein. When specific statements are presented separately,
the pertinent notes shall accompany such statements unless cross-referencing
is appropriate.
a. Principles
of consolidation or combination. With regard to consolidated or combined
financial statements, refer to Rules 3A-01
to 3A-08 for requirements for supplemental information in notes to
the financial statements.
b. Assets
subject to lien. Assets mortgaged pledged, or otherwise subject to
lien, and the approximate amounts thereof, shall be designated and the
obligations collateralized briefly identified.
c. Defaults.
The facts and amounts concerning any default in principal, interest, sinking
fund, or redemption provisions with respect to any issue of securities
or credit agreements, or any breach of covenant of a related indenture
or agreement, which default or breach existed at the date of the most
recent balance sheet being filed and which has not been subsequently cured,
shall be stated in the notes to the financial statements. If a default
or breach exists but acceleration of the obligation has been waived for
a stated period of time beyond the date of the most recent balance sheet
being filed, state the amount of the obligation and the period of the
waiver.
d.
Preferred shares.
1. Aggregate
preferences on involuntary liquidation, if other than par or stated value,
shall be shown parenthetically in the equity section of the balance sheet.
2. Disclosure
shall be made of any restriction upon retained earnings that arises from
the fact that upon involuntary liquidation the aggregate preferences of
the preferred shares exceeds the par or stated value of such shares.
e.
Restrictions which
limit the payment of dividends by the registrant.
1. Describe
the most significant restrictions, other than as reported under paragraph
(d) of this section, on the payment of dividends by the registrant, indicating
their sources, their pertinent provisions, and the amount of retained
earnings or net income restricted or free of restrictions.
2. Disclose
the amount of consolidated retained earnings which represents undistributed
earnings of 50 percent or less owned persons accounted for by the equity
method.
3.
The disclosures
in paragraph (3)(i) and (ii) in
this section shall be provided when the restricted net assets of consolidated
and unconsolidated subsidiaries and the parent's equity in the undistributed
earnings of 50 percent or less owned persons accounted for by the equity
method together exceed 25 percent of consolidated net assets as of the
end of the most recently completed fiscal year. For purposes of this test,
restricted net assets of subsidiaries shall mean that amount of the registrant's
proportionate share of net assets (after intercompany eliminations) reflected
in the balance sheets of its consolidated and unconsolidated subsidiaries
as of the end of the most recent fiscal year which may not be transferred
to the parent company in the form of loans, advances or cash dividends
by the subsidiaries without the consent of a third party (i.e., lender,
regulatory agency, foreign government, etc.). Not all limitations on transferability
of assets are considered to be restrictions for purposes of this test,
which considers only specific third party restrictions on the ability
of subsidiaries to transfer funds outside of the entity. For example,
the presence of subsidiary debt which is secured by certain of the subsidiary's
assets does not constitute a restriction under this rule. However, if
there are any loan provisions prohibiting dividend payments, loans or
advances to the parent by a subsidiary, these are considered restrictions
for purposes of computing restricted net assets. When a loan agreement
requires that a subsidiary maintain certain working capital, net tangible
asset, or net asset levels, or where formal compensating arrangements
exist, there is considered to be a restriction under the rule because
the lender's intent is normally to preclude the transfer by dividend or
otherwise of funds to the parent company. Similarly, a provision which
requires that a subsidiary reinvest all of its earnings is a restriction,
since this precludes loans, advances or dividends in the amount of such
undistributed earnings by the entity. Where restrictions on the amount
of funds which may be loaned or advanced differ from the amount restricted
as to transfer in the form of cash dividends, the amount least restrictive
to the subsidiary shall be used. Redeemable preferred stocks (Rule
5-02.28) and minority interests shall be deducted in computing net
assets for purposes of this test.
i. Describe
the nature of any restrictions on the ability of consolidated subsidiaries
and unconsolidated subsidiaries to transfer funds to the registrant in
the form of cash dividends, loans or advances (i.e., borrowing arrangements,
regulatory restraints, foreign government, etc.)
ii. Disclose
separately the amounts of such restricted net assets for unconsolidated
subsidiaries and consolidated subsidiaries as of the end of the most recently
completed fiscal year.
f. Significant
changes in bonds, mortgages and similar debt. Any significant changes
in the authorized or issued amounts of bonds, mortgages and similar debt
since the date of the latest balance sheet being filed for a particular
person or group shall be stated.
g.
Summarized financial
information of subsidiaries not consolidated and 50 percent or less owned
persons.
1.
The summarized
information as to assets, liabilities and results of operations as detailed
in Rule 1-02(bb) shall be presented
in notes to the financial statements on an individual or group basis for:
i. Subsidiaries
not consolidated; or
ii.
For 50
percent or less owned persons accounted for by the equity method by the
registrant or by a subsidiary of the registrant, if the criteria in
Rule 1-02(w) for a significant subsidiary
are met:
A. Individually
by any subsidiary not consolidated or any 50% or less owned person; or
B. On
an aggregated basis by any combination of such subsidiaries and persons.
2. Summarized
financial information shall be presented insofar as is practicable as
of the same dates and for the same periods as the audited consolidated
financial statements provided and shall include the disclosures prescribed
by Rule 1-02(bb). Summarized information
of subsidiaries not consolidated shall not be combined for disclosure
purposes with the summarized information of 50 percent or less owned persons.
h.
Income tax expense.
1.
Disclosure shall
be made in the income statement or a note thereto, of
i.
the components of income (loss) before income tax expense (benefit) as
either domestic or foreign;
ii.
the components
of income tax expense, including
A.
taxes currently payable and
B. the
net tax effects, as applicable, of timing differences (indicate separately
the amount of the estimated tax effect of each of the various types of
timing differences, such as depreciation, warranty costs, etc., where
the amount of each such tax effect exceeds five percent of the amount
computed by multiplying the income before tax by the applicable statutory
Federal income tax rate; other differences may be combined.)
Note:
Amounts applicable to United States Federal income taxes, to foreign
income taxes and the other income taxes shall be stated separately for
each major component. Amounts applicable to foreign income (loss) and
amounts applicable to foreign or other income taxes which are less than
five percent of the total of income before taxes or the component of tax
expense, respectively, need not be separately disclosed. For purposes
of this rule, foreign income (loss) is defined as income (loss) generated
from a registrant's foreign operations, i.e., operations that are located
outside of the registrant's home country.
2. Provide
a reconciliation between the amount of reported total income tax expense
(benefit) and the amount computed by multiplying the income (loss) before
tax by the applicable statutory Federal income tax rate, showing the estimated
dollar amount of each of the underlying causes for the difference. If
no individual reconciling item amounts to more than five percent of the
amount computed by multiplying the income before tax by the applicable
statutory Federal income tax rate, and the total difference to be reconciled
is less than five percent of such computed amount, no reconciliation need
be provided unless it would be significant in appraising the trend of
earnings. Reconciling items that are individually less than five percent
of the computed amount may be aggregated in the reconciliation. The reconciliation
may be presented in percentages rather than in dollar amounts. Where the
reporting person is a foreign entity, the income tax rate in that person's
country of domicile should normally be used in making the above computation,
but different rates should not be used for subsidiaries or other segments
of a reporting entity. When the rate used by a reporting person is other
than the United States Federal corporate income tax rate, the rate used
and the basis for using such rate shall be disclosed.
3. Paragraphs
(h)(1) and
(2)
of this section shall be applied in the following manner to financial
statements which reflect the adoption of Statement of Financial Accounting
Standards No. 109, Accounting for Income Taxes.
i. The
disclosures required by paragraph (h)(1)(ii)
and by the parenthetical instruction at the end of
paragraph
(h)(1) and by the introductory sentence of
paragraph
(h)(2) of this section shall not apply.
ii. The
instructional note between paragraphs (h)(1)
and (2) and the balance of the requirements
of paragraphs (h)(1) and (2) shall continue to apply.
i.
Warrants or rights
outstanding. Information with respect to warrants or rights outstanding
at the date of the related balance sheet shall be set forth as follows:
1.
Title of issue of securities called for by warrants or rights.
2.
Aggregate amount of securities called for by warrants or rights outstanding.
3. Date
from which warrants or rights are exercisable.
4.
Price at which warrant or right is exercisable.
j. [Reserved]
k.
Related party transactions
which affect the financial statements.
1. Related
party transactions should be identified and the amounts stated on the
face of the balance sheet, income statement, or statement of cash flows.
2.
In cases where
separate financial statements are presented for the registrant, certain
investees, or subsidiaries, separate disclosure shall be made in such
statements of the amounts in the related consolidated financial statements
which are
i. eliminated
and
ii.
not eliminated.
3. Also,
any intercompany profits or losses resulting from transactions with related
parties and not eliminated and the effects thereof shall be disclosed.
l. [Reserved.]
m.
Repurchase and reverse
repurchase agreements.
1.
Repurchase agreements
(assets sold under agreements to repurchase).
i. If,
as of the most recent balance sheet date, the carrying amount (or market
value, if higher than the carrying amount or if there is no carrying amount)
of the securities or other assets sold under agreements to repurchase
("repurchase agreements") exceeds 10% of total assets, disclose
separately in the balance sheet the aggregate amount of liabilities incurred
pursuant to repurchase agreements including accrued interest payable thereon.
ii.
A.
If,
as of the most recent balance sheet date, the carrying amount (or market
value, if higher than the carrying amount) of securities or other assets
sold under repurchase agreements, other than securities or assets specified
in (1)(ii)(B) of this section, exceeds 10% of total assets, disclose in
an appropriately captioned footnote containing a tabular presentation,
segregated as to type of such securities or assets sold under agreements
to repurchase (e.g., U.S. Treasury obligations, U.S. Government agency
obligations and loans), the following information as of the balance sheet
date for each such agreement or group of agreements (other than agreements
involving securities or assets specified in
(1)(ii)(B)
of this section) maturing (1) overnight; (2) term up to
30 days; (3) term of 30 to 90 days; (4) term over 90 days
and (5) demand:
i. carrying amount and market value of the assets sold
under agreement to repurchase, including accrued interest plus any cash
or other assets on deposit under the repurchase agreements; and
ii. the repurchase liability associated with such transaction
or group of transactions and the interest rate(s) thereon.
B.
For purposes of (1)(ii)(A) of
this section only, do not include securities or other assets for which
unrealized changes in market value are reported in current income or which
have been obtained under reverse repurchase agreements.
iii. If,
as of the most recent balance sheet date, the amount at risk under repurchase
agreements with any individual counterparty or group of related counterparties
exceeds 10% of stockholders' equity (or in the case of investment companies,
net asset value), disclose the name of each such counterparty or group
of related counterparties, the amount at risk with each, and the weighted
average maturity of the repurchase agreements with each. The amount at
risk under repurchase agreements is defined as the excess of carrying
amount (or market value, if higher than the carrying amount or if there
is no carrying amount) of the securities or other assets sold under agreement
to repurchase, including accrued interest plus any cash or other assets
on deposit to secure the repurchase obligation, over the amount of the
repurchase liability (adjusted for accrued interest). (Cash deposits in
connection with repurchase agreements shall not be reported as unrestricted
cash pursuant to Rule 5.02.1.)
2.
Reverse repurchase
agreements (assets purchased under agreements to resell).
i.
If, as of
the most recent balance sheet date, the aggregate carrying amount of "reverse
repurchase agreements" (securities or other assets purchased under
agreements to resell) exceeds 10% of total assets:
A. disclose
separately such amount in the balance sheet; and
B.
disclose
in an appropriately captioned footnote:
1. the registrant's policy with regard to taking possession
of securities or other assets purchased under agreements to resell; and
2. whether or not there are any provisions to ensure
that the market value of the underlying assets remains sufficient to protect
the registrant in the event of default by the counterparty and if so,
the nature of those provisions.
ii. If,
as of the most recent balance sheet date, the amount of risk under reverse
repurchase agreements with any individual counterparty or group of related
counterparties exceeds 10% of stockholders' equity (or in the case of
investment companies, net asset value), disclose the name of each such
counterparty or group of related counterparties, the amount at risk with
each, and the weighted average maturity of the reverse repurchase agreements
with each. The amount at risk under reverse repurchase agreements is defined
as the excess of the carrying amount of the reverse repurchase agreements
over the market value of assets delivered pursuant to the agreements by
the counterparty to the registrant (or to a third party agent that has
affirmatively agreed to act on behalf of the registrant) and not returned
to the counterparty, except in exchange for their approximate market value
in a separate transaction.
n.
Accounting policies
for certain derivative instruments. Disclosures regarding accounting
policies shall include descriptions of the accounting policies used for
derivative financial instruments and derivative commodity instruments
and the methods of applying those policies that materially affect the
determination of financial position, cash flows, or results of operation.
This description shall include, to the extent material, each of the following
items:
1. A
discussion of each method used to account for derivative financial instruments
and derivative commodity instruments;
2.
The types of derivative financial instruments and derivative commodity
instruments accounted for under each method;
3.
The criteria required to be met for each accounting method used, including
a discussion of the criteria required to be met for hedge or deferral
accounting and accrual or settlement accounting (e.g., whether and how
risk reduction, correlation, designation, and effectiveness tests are
applied);
4.
The accounting method used if the criteria specified in paragraph (n)(3)
of this section are not met;
5.
The method used to account for terminations of derivatives designated
as hedges or derivatives used to affect directly or indirectly the terms,
fair values, or cash flows of a designated item;
6.
The method used to account for derivatives when the designated item matures,
is sold, is extinguished, or is terminated. In addition, the method used
to account for derivatives designated to an anticipated transaction, when
the anticipated transaction is no longer likely to occur; and
7.
Where and when derivative financial instruments and derivative commodity
instruments, and their related gains and losses, are reported in the statements
of financial position, cash flows, and results of operations.
Instructions to Paragraph (n)
1.
For purposes
of this paragraph (n), derivative financial instruments and derivative
commodity instruments (collectively referred to as "derivatives")
are defined as follows:
i. Derivative
financial instruments have the same meaning as defined by generally accepted
accounting principles (see, e.g., Financial Accounting Standards Board
("FASB"), Statement of Financial Accounting Standards No. 119,
"Disclosure about Derivative Financial Instruments and Fair Value
of Financial Instruments," ("FAS 119") paragraphs 5-7,
(October 1994)), and include futures, forwards, swaps, options, and other
financial instruments with similar characteristics.
ii. Derivative
commodity instruments include, to the extent such instruments are not
derivative financial instruments, commodity futures, commodity forwards,
commodity swaps, commodity options, and other commodity instruments with
similar characteristics that are permitted by contract or business custom
to be settled in cash or with another financial instrument. For purposes
of this paragraph, settlement in cash includes settlement in cash of the
net change in value of the derivative commodity instrument (e.g., net
cash settlement based on changes in the price of the underlying commodity).
2. For
purposes of paragraphs (n)(2),
(n)(3), (n)(4),
and (n)(7), the required disclosures
should address separately derivatives entered into for trading purposes
and derivatives entered into for purposes other than trading. For purposes
of this paragraph, trading purposes has the same meaning as defined by
generally accepted accounting principles (see, e.g., FAS 119, paragraph
9a (October 1994)).
3. For
purposes of paragraph (n)(6), anticipated
transactions means transactions (other than transactions involving existing
assets or liabilities or transactions necessitated by existing firm commitments)
an enterprise expects, but is not obligated, to carry out in the normal
course of business (see, e.g., FASB, Statement of Financial Accounting
Standards No. 80, "Accounting for Futures Contracts," paragraph
9, (August 1984)).
4. Registrants
should provide disclosures required under paragraph
(n) in filings with the Commission that include financial statements
of fiscal periods ending after June 15, 1997.
Regulatory History |
|
45 FR 63669, Sept.
25, 1980 46 FR 56179, Nov. 16, 1981 50 FR 25215, June 18, 1985 50 FR 49532, Dec. 3, 1985
51 FR 3770, Jan. 30, 1986 57 FR 45293, Oct. 1, 1992
59 FR 65636, Dec. 20, 1994 62 FR 6044, 6063, Feb. 10, 1997 |
|